Bringing Med to MedTech - Physician, Scientist, Photographer, Traveler, Berliner, Immigrant š©šŖšŗšø - Views=My own, Like/RTā Endorsement; Haemonetics employee
Brookline, MA
Joined August 2019
- Tweets1.9K
- Following202
- Followers299
- Likes1.6K
Age-Adjusted D-Dimer Cutoff in Suspected Deep Vein Thrombosis jamanetwork.com/journals/jamā¦
Like a Fine WineāAging the D-Dimer to Improve Value and Clinical Efficiency
Nice title for this editorial
jamanetwork.com/journals/jamā¦
Preāoperative anaemia, red blood cell transfusion and mortality after cardiac surgery: a Netherlands Heart Registration mediation analysis - Groenewegen - Anaesthesia - Wiley Online Library associationofanaesthetists-pā¦
Our article on the trial of the HN cartridge for the TEGĀ® 6s system featured in current issue of ā¦ā¦@_Anesthesiology.ā©
A big thank you to our team of coāauthors, local PIs and their teams, and all the participating patients who made this possible. linkedin.com/posts/anesthesiā¦
TEGĀ® 6s Heparin Neutralization Cartridge for Hemostatic... : Anesthesiology journals.lww.com/anesthesiolā¦
Football & Freunde š©šŖšŗšø ā Germany Day at ā¦@Patriotsā© Training Camp 2025.
ā¦@SebVollmerā© ā¦@themarkuskuhnā© ā¦@Fred_Kirschā© ā¦@patsdeutschā©
Jan Hartmann, MD retweeted
Coagulation factor XI is a promising target for safer anticoagulants. In a series of preclinical studies, novel factor XI-targeting GalNAc-siRNA RBD4059 showed high potency & long-lasting antithrombotic effects w/out ā¬ļø š©ø risk. jacc.org/doi/10.1016/j.jacbtā¦
#JACCBTS #CardioX #cvCoag
Last night at #ISTH2025, we honored a gentle giantāDr. Hau Kwaan, Prof.em. at ā¦ā¦@NorthwesternMedā©. A true #Fibrinolysis pioneer with 400+ articles since the 1950sāstill contributing posters in his 90s. Thanks, Mark Walsh, for a moving laudatio. linkedin.com/posts/janhartmaā¦
Jan Hartmann, MD retweeted
Managing surgical bleeding is complex, but #viscoelastic testing is helping clinicians make more informed decisions. It can provide real-time insights and help guide targeted treatments to optimize perioperative and major bleeding management. ow.ly/B59z50VWH5z
This podcast episode with my favorite hematologist is a great resource for Sickle Cell Disease patients and their families and friends. #SCD podcasts.apple.com/us/podcasā¦
Emergent cardiac surgery, andexanet alfaāinduced heparin resistance, a... sciencedirect.com/science/arā¦
Please discuss. I will observeā¦ šæ šæ šæ
āOverall, there was little to no evidence of a difference between blood transfusion strategies for mortality or thromboembolic events.ā
cochrane.org/CD012635/CENTRAā¦
Jan Hartmann, MD retweeted
Congratulations to Andrea Natale, MD, FHRS, winner of the 2025 Wilton Wells Webster Lectureship Award at #HRS2025. His lectureship was titled "Innovations in the Advancement of Care in Patients with AF in the Last 3 Decades: A Chronicle of My Journey." #EPeeps #LectureshipAward
Looking forward to this event in June. Press release here: newswire.com/news/german-ameā¦
Jan Hartmann, MD retweeted
In the SINGLE SHOT CHAMPION trial, pulsed field ablation was noninferior to cryoballoon ablation with respect to the incidence of a first recurrence of atrial tachyarrhythmia, as assessed by continuous rhythm monitoring.
Full trial results and Research Summary: nej.md/4iH5zQe
#Afib
ALT The New England Journal of Medicine Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation A Research Summary based on Reichlin T et al. | 10.1056/NEJMoa2502280 | Published on March 31, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
